Dr. Agarwal's Health Care Limited - Monitoring Agency Report for the quarter ended March 31, 2026, is attached.
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
ICRA Limited submitted its quarterly monitoring report for Dr. Agarwal's Health Care Limited's IPO proceeds utilization as of March 31, 2026. The company raised Rs. 300 crore in net IPO proceeds (excluding OFS). Of this, Rs. 276.86 crore (92.3%) has been utilized: Rs. 195 crore fully deployed for debt repayment and Rs. 69.21 crore for general corporate purposes including medical equipment (Rs. 25.28 crore), interior works (Rs. 16.53 crore), acquisition deferred payments (Rs. 23.11 crore), and other items. The remaining Rs. 23.14 crore is parked in fixed deposits with banks and escrow accounts. ICRA confirmed no deviation from the stated objects of the issue, with all projects on schedule.
Positive signal for shareholders as the monitoring agency confirms proper utilization of IPO funds with no deviations from stated objectives. The company is progressing as planned on debt reduction and business expansion.